Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work?

被引：3
作者：
Rigante, Donato [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Pediat, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
来源：
INTERNAL AND EMERGENCY MEDICINE | 2017年 / 12卷 / 02期
关键词：
Etanercept; Adalimumab; Familial Mediterranean Fever; Tocilizumab; Tumor Necrosis Factor Receptor;
D O I：
10.1007/s11739-016-1570-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [41] Combination Therapy With Tumor Necrosis Factor Inhibitors in Psoriasis Treatment
    Famenini, Shannon
    Wu, Jashin J.
    CUTIS, 2013, 92 (03): : 140 - 147
  • [42] Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (06): : 516 - +
  • [43] Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy?
    Ali, Yaser M.
    Kuriya, Bindee
    Orozco, Catalina
    Cush, John J.
    Keystone, Edward C.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 9 - 17
  • [44] Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
    Lim, Mie Jin
    Kwon, Seong Ryul
    Joo, Kowoon
    Son, Min Jung
    Park, Shin-Goo
    Park, Won
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (06) : 807 - 813
  • [45] Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases
    Yasumura, Junko
    Shimizu, Masaki
    Toma, Tomoko
    Yashiro, Masato
    Yachie, Akihiro
    Okada, Satoshi
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis
    Renton, William D.
    Jung, Jennifer
    Palestine, Alan G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (10):
  • [47] Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes
    Banoth, Balaji
    Sutterwala, Fayyaz S.
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12) : 4235 - 4237
  • [48] Determinants Associated with Work Participation in Patients with Established Rheumatoid Arthritis Taking Tumor Necrosis Factor Inhibitors
    Manders, Sofie H. M.
    Kievit, Wietske
    Braakman-Jansen, Annemarie L. M. A.
    Brus, Herman L. M.
    Hendriks, Lidy
    Fransen, Jaap
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C. M.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1263 - 1269
  • [49] Risk of infection during treatment with tumor necrosis factor-α inhibitors
    Gaemperli A.
    Hauser T.
    Speck R.
    Zeitschrift für Rheumatologie, 2006, 65 (1) : 24 - 31
  • [50] Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles
    Anderson, PJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) : 19 - 22
12345